BMAL1 silencing as a promising chemosensitizing strategy for triple-negative breast cancer.

Saved in:
Bibliographic Details
Title: BMAL1 silencing as a promising chemosensitizing strategy for triple-negative breast cancer.
Authors: Wang LY; School of Materials Science and Engineering, Zhejiang University, Hangzhou, 310058, China.; Research Centre for Industries of the Future, Westlake University, Hangzhou, 310030, China.; Department of Materials Science and Engineering, School of Engineering, Westlake University, Hangzhou, 310030, China.; Institute of Advanced Technology, Westlake Institute for Advanced Study, Hangzhou, 310024, China., Xu XH; School of Materials Science and Engineering, Zhejiang University, Hangzhou, 310058, China.; Research Centre for Industries of the Future, Westlake University, Hangzhou, 310030, China.; Department of Materials Science and Engineering, School of Engineering, Westlake University, Hangzhou, 310030, China.; Institute of Advanced Technology, Westlake Institute for Advanced Study, Hangzhou, 310024, China., Xuan WJ; Research Centre for Industries of the Future, Westlake University, Hangzhou, 310030, China.; Department of Materials Science and Engineering, School of Engineering, Westlake University, Hangzhou, 310030, China.; Institute of Advanced Technology, Westlake Institute for Advanced Study, Hangzhou, 310024, China., Bi XY; Institute of Advanced Technology, Westlake Institute for Advanced Study, Hangzhou, 310024, China.; School of Science, Westlake University, Hangzhou, 310030, China., Zhou Q; Research Centre for Industries of the Future, Westlake University, Hangzhou, 310030, China. zhouqin@westlake.edu.cn.; Department of Materials Science and Engineering, School of Engineering, Westlake University, Hangzhou, 310030, China. zhouqin@westlake.edu.cn.; Institute of Advanced Technology, Westlake Institute for Advanced Study, Hangzhou, 310024, China. zhouqin@westlake.edu.cn.; School of Medicine, Westlake University, Hangzhou, 310030, China. zhouqin@westlake.edu.cn.
Source: Acta pharmacologica Sinica [Acta Pharmacol Sin] 2026 Mar 24. Date of Electronic Publication: 2026 Mar 24.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 100956087 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1745-7254 (Electronic) Linking ISSN: 16714083 NLM ISO Abbreviation: Acta Pharmacol Sin Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1745-7254
DOI:10.1038/s41401-026-01788-8